# In their own words: A qualitative study of patient narratives on daily life after breast cancer radiotherapy

**Authors:** Madeline S. Therrien, Simone M.B. Mingels, Rianne R.R. Fijten, Daniela B. Raphael, Marcel Stam, Desiree van den Bongard, Olga C. Damman, Liesbeth J. Boersma

PMC · DOI: 10.1016/j.pecinn.2026.100468 · PEC Innovation · 2026-03-06

## TL;DR

This study explores how breast cancer survivors experience radiotherapy side effects in daily life and how these stories can improve patient decision-making tools.

## Contribution

This is the first qualitative study to examine how breast cancer patients live with radiotherapy side effects and how these narratives can enhance shared decision-making.

## Key findings

- Participants described locoregional and general side effects affecting daily activities and self-perception.
- Three overarching themes—comparisons to the pre-treatment self, acceptance, and work—captured broader quality of life impacts.
- Narratives were classified using a taxonomy to inform the selection of stories for a patient decision aid.

## Abstract

To explore how former breast cancer patients (BCPs) experience the daily-life impact of radiotherapy (RT) side effects and to examine how these narratives can inform the selection of patient stories for the BRASA patient decision aid (BRASA-PtDA).

Semi-structured interviews were conducted with fourteen former BCPs who completed adjuvant RT 6 months–5 years earlier. Thematic analysis identified locoregional, general, and overarching impacts on quality of life (QoL). Narrative excerpts were classified by type, purpose, and evaluative valence.

Participants described locoregional side effects (pain, reduced arm function, changes in breast appearance, skin irritation) and general effects (fatigue, concentration difficulties) affecting daily activities and self-perception. Three overarching themes—comparisons to the pre-treatment self, acceptance, and work—captured broader QoL impacts. All narratives were experiential or outcome-focused, mostly negative in valence. Thirteen balanced narratives were selected for potential inclusion in the BRASA-PtDA.

Narratives from BCPs illustrate how RT side effects shape daily life and overall QoL. Structured narrative classification provided a transparent method for selecting stories for a decision aid. Future research should examine how different narrative types influence patient engagement and decision outcomes.

To our knowledge, this is the first qualitative study to examine how BCPs live with RT side effects, highlighting impacts on daily life that are under-communicated in current practice in the Netherlands and internationally. Findings provide rich insights for improving risk communication and shared decision making by moving beyond symptom-focused information to incorporate patients' lived experiences.

•Explored daily-life impacts of breast cancer radiotherapy side effects.•Identified cross-cutting QoL themes: acceptance, work, and comparisons to pre-treatment self.•Applied deductive thematic analysis using a predefined codebook.•Classified patient stories via the Taxonomy of Patient Narratives in Decision Aids.•Informed narrative selection for the BRASA-PtDA to support shared decisions.

Explored daily-life impacts of breast cancer radiotherapy side effects.

Identified cross-cutting QoL themes: acceptance, work, and comparisons to pre-treatment self.

Applied deductive thematic analysis using a predefined codebook.

Classified patient stories via the Taxonomy of Patient Narratives in Decision Aids.

Informed narrative selection for the BRASA-PtDA to support shared decisions.

## Linked entities

- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Diseases:** pain (MESH:D010146), concentration difficulties (MESH:C567712), skin irritation (MESH:D012871), fatigue (MESH:D005221), breast cancer (MESH:D001943)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12993325/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12993325/full.md

---
Source: https://tomesphere.com/paper/PMC12993325